Status:
UNKNOWN
Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Functional Constipation
Irritable Bowel Syndrome
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The purpose of this project is to study the the efficacy and safety of probiotics implantation through infusion during colonoscopy in the treatment of functional constipation and irritable bowel syndr...
Eligibility Criteria
Inclusion
- Patients undergoing for colonoscopy
- Meet Rome IV diagnostic criteria for functional constipation or irritable bowel syndrome
- Voluntarily participate in this clinical study and sign the informed consent.
Exclusion
- Use of probiotics or antibiotics within the past 4 weeks
- History of intestinal surgery
- History of severe liver and kidney disease
- History of cardiovascular and cerebrovascular diseases
- History of neuropsychiatric diseases
- Pregnant women or lactating women
- Allergic to any ingredients of the live bacteria tablet
Key Trial Info
Start Date :
July 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05366335
Start Date
July 4 2022
End Date
January 1 2023
Last Update
August 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 710061